Many recent reports, especially in the field of tumor immunology, have investigated the expression of the immune checkpoint molecules TIGIT, CD226 and CD155 and their possible role in immune regulation, while fewer papers have been published in the context of pregnancy. Here, CD226 is linked to neoplasm.